1. Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR‐HF substudy. (30th May 2019) Authors: Okonko, Darlington O.; Jouhra, Fadi; Abu‐Own, Huda; Filippatos, Gerasimos; Colet, Josep Comin; Suki, Chainey; Mori, Claudio; Ponikowski, Piotr; Anker, Stefan D. Journal: ESC heart failure Issue: Volume 6:Number 4(2019) Page Start: 621 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intravenous ferric carboxymaltose in iron‐deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR‐HF trial. (November 2013) Authors: Filippatos, Gerasimos; Farmakis, Dimitrios; Colet, Josep Comin; Dickstein, Kenneth; Lüscher, Thomas F.; Willenheimer, Ronnie; Parissis, John; Gaudesius, Giedrius; Mori, Claudio; von, Barbara; Greenlaw, Nicola; Ford, Ian; Ponikowski, Piotr; Anker, Stefan D. Journal: European journal of heart failure Issue: Volume 15:Number 11(2013) Page Start: 1267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR‐HF study. (11th February 2015) Authors: Ponikowski, Piotr; Filippatos, Gerasimos; Colet, Josep Comin; Willenheimer, Ronnie; Dickstein, Kenneth; Lüscher, Thomas; Gaudesius, Giedrius; von Eisenhart Rothe, Barbara; Mori, Claudio; Greenlaw, Nicola; Ford, Ian; Macdougall, Iain; Anker, Stefan D.; for the FAIR‐HF Trial Investigators Journal: European journal of heart failure Issue: Volume 17:Number 3(2015) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗